Latest Breaking News On - European organization for research - Page 1 : comparemela.com

Summit Therapeutics Inc. (NASDAQ:SMMT) Q1 2024 Earnings Call Transcript

Summit Therapeutics Inc. reports earnings inline with expectations. Reported EPS is $-0.06 EPS, expectations were $-0.06.

Study Supports Use of EORTC Item Library to Assess Lymphoma Symptoms

Clinician and patient interviews indicated satisfaction with the items presented to help describe patient symptoms with different lymphomas.

Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Dosed first patient in Phase 2 trial of BDTX-1535 in 1L patients with non-classical EGFRm NSCLCClinical data on track for Q3 2024 in Phase 2 trial.

FDA's Office of Prescription Drug Promotion Issues Its First Untitled Letter of the Year to Novartis for Misleading Statement Relating to KISQALI® | Sheppard Mullin Richter & Hampton LLP

On January 18, 2024, the Office of Prescription Drug Promotion (OPDP) of the U.S. Food and Drug Administration (FDA) issued its first untitled letter of the new year to Novartis.

FDA Issues Letter to Novartis for Misleading Statement